INCOME STATEMENT
Akums Drugs & Pharmaceuticals Ltd.
BSE
Jul 16
562.25
+4.70 (+ 0.84%)
Volume
13008
Prev. Close
557.55
Open Price
558.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 16
561.60
+4.75 (+ 0.85%)
Volume
161500
Prev. Close
556.85
Open Price
556.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE09XN01023
|
Market Cap. ( ₹ in Cr. )
|
8839.25
|
P/BV
|
3.12
|
Book Value ( ₹ )
|
180.08
|
|
BSE Code
|
544222
|
52 Week High/Low ( ₹ )
|
1176/405
|
FV/ML
|
2/1
|
P/E(X)
|
26.14
|
|
NSE Code
|
AKUMSEQ
|
Book Closure
|
|
EPS ( ₹ )
|
21.49
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 1262.25 | 1278.41 | 1117.92 |
| Other Operating Revenues | 49.54 | 165.71 | 168.91 |
| Total Operating Revenues | 1311.78 | 1444.12 | 1286.83 |
| | | | |
| Other Income | 124.19 | 94.12 | 96.15 |
| Total Revenue | 1435.98 | 1538.24 | 1382.98 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 811.06 | 867.24 | 791.21 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -10.05 | 6.44 | -3.06 |
| Employee Benefit Expenses | 201.74 | 175.28 | 147.30 |
| Finance Costs | 15.31 | 18.31 | 13.18 |
| Depreciation And Amortisation Expenses | 39.55 | 32.69 | 30.00 |
| Other Expenses | 170.54 | 521.82 | 109.50 |
| Total Expenses | 1228.14 | 1621.78 | 1088.13 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 207.84 | -83.54 | 294.85 |
| | | | |
| Exceptional Items | 0.00 | -19.39 | -144.53 |
| Profit/Loss Before Tax | 207.84 | -102.93 | 150.32 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 49.27 | 46.99 | 41.33 |
| Deferred Tax | -0.71 | 14.18 | -16.11 |
| Tax For Earlier Years | -1.72 | 1.35 | -0.33 |
| Total Tax Expenses | 46.84 | 62.52 | 24.89 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 161.00 | -165.45 | 125.43 |
| | | | |
| Profit/Loss From Continuing Operations | 161.00 | -165.45 | 125.43 |
| | | | |
| Profit/Loss For The Period | 161.00 | -165.45 | 125.43 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | 10.76 | -11.56 | 8.77 |
| Diluted EPS (Rs.) | 10.76 | -11.56 | 8.77 |